Chemo-radiotherapy for Locally Advanced Head and Neck Cancer--Long-term Results of a Phase II Trial

Author： Dinges S.   Budach V.   Stuschke M.   Budach W.   Boehmer D.   Schrader M.   Jahnke K.   Sack H.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.7, 1997-06, pp. : 1152-1155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer - A randomised phase II EORTC trial

By Bartelink H.   Van den Bogaert W.   Horiot J.-C.   Jager J.   van Glabbeke M.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 667-673

Elsevier

Access to resources Recommend Favorite

Role and extent of neck dissection for persistent nodal disease following chemo-radiotherapy for locally advanced head and neck cancer: How much is enough?

By Sandhu A.   Rao N.   Giri S.   He F.   Karakla D.   Wadsworth T.   McGaughey D.   Silverberg M.  

Acta Oncologica, Vol. 47, Iss. 5, 2008-05 ,pp. : 948-953

Informa Healthcare

Access to resources Recommend Favorite

Phase II Trial of a Simultaneous Radiochemotherapy with Cisplatinum and Paclitaxel in Combination with Hyperfractionated-Accelerated Radiotherapy in Locally Advanced Head and Neck Tumors

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 325-334

Humana Press, Inc

Access to resources Recommend Favorite

Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC)

By Vestermark Lene   Jacobsen Anders   Qvortrup Camilla   Hansen Flemming   Bisgaard Claus   Baatrup Gunnar   Rasmussen Peter   Pfeiffer Per  

Acta Oncologica, Vol. 47, Iss. 3, 2007-12 ,pp. : 428-433

Informa Healthcare

Access to resources Recommend Favorite

Phase II Trial of Intraperitoneal Cisplatin with Intravenous Doxorubicin and Cyclophosphamide in Previously Untreated Patients with Advanced Ovarian Cancer-Long-Term Follow-Up

By Morgan R.J.   Braly P.   Cecchi G.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Parker P.   Stein A.   Cho J.   Smith E.   Coluzzi P.   Najera L.   Johnson D.   Womack E.   Doroshow J.H.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 419-426

Elsevier

Access to resources Recommend Favorite